市场调查报告书
商品编码
1433378
2023-2030 年全球无菌管焊接机市场Global Sterile Tubing Welder Market 2023-2030 |
预计在预测期内(2023-2030 年),全球无菌管焊机市场将以 5.6% 的CAGR成长。支持全球无菌管焊机市场需求的主要因素包括一次性技术的使用不断增加,以及由于血癌、贫血、血友病等病例的增加而对血液和血液製品的需求不断增加,预计将进一步推动市场增长。根据世界血友病联合会2022年调查,确诊血友病人数为257,146人,A型血友病患者为208,957人,B型血友病患者为42,203人,血友病类型未知或未报告的血友病人数为5,986人。
此外,2022 年 11 月,《老年人口统计:美国老化肖像》一文报道,有 5,410 万名成年人(占美国人口的 16.3%)是老年人,其中包括 65 岁及以上的老年人。预计到 2040 年,老年人口将增至 22.0%,到 2060 年将增至 25.0%。相较之下,取代管焊机的新技术进步阻碍了无菌管焊机市场的成长。 2021 年 9 月,多佛旗下的 Colder Products Co. 推出了一款新型超紧凑型无菌连接器,为生物製药製造商的小批量封闭无菌製程提供了急需的管道焊接替代方案。 MicroCNX (TM) 系列连接器是业界首款无菌连接器,旨在提供一种简单、高效的方法来连接小型组件中的管道。
Global Sterile Tubing Welder Market Size, Share & Trends Analysis Report by Mode (Manual and Automatic), By Application, (Biopharmaceutical, Blood Processing, Diagnostic Laboratories, and Others), and by End-use (Hospitals, Blood Centers, and Others), Forecast Period (2023-2030)
The global sterile tubing welder market is anticipated to grow at a CAGR of 5.6% during the forecast period (2023-2030). The primary factor supporting the demand for the global sterile tubing welder market globally includes the rising usage of single-use technologies and increasing demand for blood and blood products due to increasing cases of blood cancer, anemia, hemophilia, and more are anticipated to further boost the market growth. According to the World Federation of Hemophilia Survey 2022, number of people identified with Hemophilia were 257,146, people with hemophilia A were 208,957, people with hemophilia B were 42,203, and the people with hemophilia type unknown or type not reported 5,986.
Further, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 years and above. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060. In contrast, entrance of a new technical advancement to replace the tub welder hinder the sterile tubing welder market growth. In September 2021, Colder Products Co., part of Dover, launched a new ultra-compact sterile connector providing biopharmaceutical manufacturers a much-required alternative to tube welding for their small-volume closed aseptic processes. MicroCNX™ Series Connectors are the industry's first aseptic connectors designed to provide a simple, efficient method of connecting tubing in small-format assemblies.
The global sterile tubing welder market is segmented by mode, application, and end-use. Based on the mode, the market is sub-segmented into manual and automatic. Based on the application, the market is sub-segmented into biopharmaceutical, blood processing, diagnostic laboratories, and others. Further, based on end-use, the market is sub-segmented into hospitals, blood centers, and others. Where others include research clinics. Among the mode, the automatic sub-segment is anticipated to hold the largest market share during the forecast period, owing to the reducing the need for manual labor and improving production throughput, and cost-effectiveness.
Among the end-use, hospitals sub-segment expected to grow over the forecast period. In hospitals, the growing adoption of sophisticated devices to reduce patient turnaround time and meet the increasing demand. The use of complex, sophisticated devices have, in turn, led hospitals to reevaluate sterile processing departments and equipment to meet the infection control standard. Transfusion committees in hospitals are anticipated to ensure the use of sterile equipment for quality transfusions and patient safety. According to World Health Organization 2023, 48.0% of the hospitals performing transfusions have a transfusion committee, with 62.0% of those in hospitals in high-income countries, 35.0% in upper-middle-income countries, 31 in lower-middle-income countries and 25.0% in low-income countries. In high-income countries, the most frequently transfused patient group is over 60 years of age, which accounts for up to 76.0% of all transfusions. In low-income countries, up to 54.0% of transfusions are for children under the age of 5 years. Such statistics project that the needs will increase the demand for sterile tubing welders over the forecast period.
The global sterile tubing welder market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the European region is anticipated to grow over the forecast period, owing to the increasing geriatric population, increasing prevalence of anemia, the rising healthcare expenditure, driving the sterile tubing welder market in Europe.
North America is expected to hold a prominent share in the sterile tubing welder market during the forecast period. The significant factors fueling the North America market is the rising prevalence of hemophilia across the North America is estimated to positively impact the sterile tubing welder market growth in upcoming years. According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of hemophilia only in the US is 12 cases per 100,000 US males for hemophilia A and 3.7 cases per 100,000 US males for hemophilia B. Furthermore, the estimated incidence of hemophilia among US births is 1 birth/ 5,617 male births for hemophilia A in birth/ 19,238 male births for hemophilia B. Such conditions such as hemophilia A result from the absence or deficiency of Factor VIII (FVIII).
The major companies serving the global sterile tubing welder market include Cytiva (Life Sciences Solutions USA LLC), Genesis BPS, Sartorius AG, Terumo BCT, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Colder Products Co., launched the new AseptiQuik G DC Series Connector designed to simplify closed-system liquid processing for biopharmaceutical manufacturers with the ability to connect and disconnect tubing aseptically using a single, sterile connection technology.